| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ... Arthritis & rheumatism 62 (9), 2569-2581, 2010 | 14529 | 2010 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 5716 | 2017 |
| Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis C Bombardier, L Laine, A Reicin, D Shapiro, R Burgos-Vargas, B Davis, ... New England Journal of Medicine 343 (21), 1520-1528, 2000 | 5408 | 2000 |
| Treating rheumatoid arthritis to target: recommendations of an international task force JS Smolen, D Aletaha, JWJ Bijlsma, FC Breedveld, D Boumpas, ... Annals of the rheumatic diseases 69 (4), 631-637, 2010 | 2888 | 2010 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2378 | 2010 |
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis MJL Peters, DPM Symmons, D McCarey, BAC Dijkmans, P Nicola, ... Annals of the rheumatic diseases 69 (2), 325-331, 2010 | 1990 | 2010 |
| American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials DT Felson, JS Smolen, G Wells, B Zhang, LHD Van Tuyl, J Funovits, ... Arthritis & Rheumatism 63 (3), 573-586, 2011 | 1858 | 2011 |
| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the rheumatic diseases 76 (6), 978-991, 2017 | 1824 | 2017 |
| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ... Annals of the rheumatic diseases 75 (1), 3-15, 2016 | 1637 | 2016 |
| 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis J Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, ... Annals of the rheumatic diseases 70 (6), 896-904, 2011 | 1501 | 2011 |
| EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update R Agca, SC Heslinga, S Rollefstad, M Heslinga, IB McInnes, MJL Peters, ... Annals of the rheumatic diseases 76 (1), 17-28, 2017 | 1381 | 2017 |
| European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo, M Dougados, ... Annals of the rheumatic diseases 75 (3), 499-510, 2016 | 1137 | 2016 |
| ASAS/EULAR recommendations for the management of ankylosing spondylitis J Zochling, D van der Heijde, R Burgos-Vargas, E Collantes, JC Davis, ... Annals of the rheumatic diseases 65 (4), 442-452, 2006 | 1106 | 2006 |
| Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial JS Smolen, JR Kalden, DL Scott, B Rozman, TK Kvien, A Larsen, ... The Lancet 353 (9149), 259-266, 1999 | 1103 | 1999 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 994 | 2008 |
| Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non … KK Jørgensen, IC Olsen, GL Goll, M Lorentzen, N Bolstad, ... The Lancet 389 (10086), 2304-2316, 2017 | 907 | 2017 |
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ... Annals of the rheumatic diseases 79 (6), 700-712, 2020 | 894 | 2020 |
| Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up M Grotle, KB Hagen, B Natvig, FA Dahl, TK Kvien BMC musculoskeletal disorders 9, 1-5, 2008 | 886 | 2008 |
| An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and … O Bruyère, C Cooper, JP Pelletier, J Branco, ML Brandi, F Guillemin, ... Seminars in arthritis and rheumatism 44 (3), 253-263, 2014 | 863 | 2014 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 845 | 2016 |
